HER2 ICD vaccine trial findings featured on KIRO7 news
CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD DNA vaccine. It was a great opportunity for us to share about cancer vaccine research happening at UW Medicine Cancer Vaccine Institute.